GSM城市站国家站国际

美国食品药品监管局拟允许NAC作为膳食补充剂销售:拟议规则公开征求意见60天

2026-11-16 · 医疗 · GSM News
美国食品药品监管局拟允许NAC作为膳食补充剂销售:拟议规则公开征求意见60天

美国食品药品监管局(FDA)11月16日发布一项拟议规则:若最终定案,将推翻把 N-乙酰-L-半胱氨酸(NAC)排除在「膳食补充剂」定义之外的认定,允许含 NAC 的产品合法以膳食补充剂名义销售,前提是产品不违反《联邦食品、药品和化妆品法》。拟议规则即日起公开征求意见60天。

FDA 在2022年3月回应两份公民请愿时曾认定,含 NAC 的产品不能算膳食补充剂;2022年8月,该局发布行业指南,对部分标为膳食补充剂的 NAC 产品行使临时执法裁量,并表示在规则制定期间将继续这一做法。

FDA 表示,经过全面审查,该局未发现 NAC 用作膳食补充剂存在安全问题;含 NAC 的产品以膳食补充剂名义在美国销售已超过30年,消费者也持续有购买需求。新规将设立名为「未被排除出膳食补充剂定义的膳食成分」的条款,NAC 将成为首个列入该条款的成分,这也是 FDA 首次动用膳食补充剂定义排除条款中的规则制定权。

FDA 称,这项行动若定案,将构成特朗普总统第14192号行政令所指的去监管行动。提交意见的具体方式见《联邦公报》刊登的拟议规则通知。

(来源:美国食品药品监管局)

FDA Proposes Rule Allowing NAC Products to Be Marketed as Dietary Supplements

The U.S. Food and Drug Administration (FDA) on November 16 issued a proposed rule that, if finalized, would reverse the exclusion of N-acetyl-L-cysteine (NAC) from the definition of "dietary supplement," allowing NAC-containing products to be lawfully marketed as dietary supplements provided they do not otherwise violate the Federal Food, Drug, and Cosmetic Act. The proposed rule will be open to public comment for 60 days.

In a March 2022 response to two citizen petitions, the FDA had said NAC-containing products cannot be dietary supplements. In August 2022, the agency issued final guidance explaining its intent to exercise temporary enforcement discretion for certain NAC products labeled as dietary supplements, and said it intends to continue that policy while the rulemaking proceeds.

The FDA said a comprehensive review did not identify any safety concerns with the use of NAC in or as a dietary supplement, and that NAC products represented as dietary supplements have been sold in the United States for over 30 years, with consumers continuing to seek access to them. The rule would create a regulation entitled "Dietary Ingredients Not Excluded from the Dietary Supplement Definition," with NAC as the first ingredient listed — the FDA's first use of this rulemaking authority.

The agency said the action, if finalized, would be a deregulatory action under President Trump's Executive Order 14192. Details on how to submit a comment are in the Federal Register notice.

(Source: U.S. Food and Drug Administration)

来源:美国食品药品监管局

发布:GSM·美国(发布链接)

图片来源:图:美国食品药品监管局(FDA)总部大楼。GSM固定图库,官方建筑照片。 / Photo: U.S. Food and Drug Administration headquarters. GSM asset library, official building photo.

GSM Global · 本篇英文版 English edition of this story

本频道最新更多 ›

← 返回医疗 全部新闻 关于我们

GSM首页白宫联邦加州南加各州社会军事司法选举世界中国城市站国家站移民宣传专题视频直播放映厅电子书电子报科技金融教育医疗影视音乐体育文旅时尚演出活动娱乐游戏生活美食户外交通汽车地产保险儿童长者留学生宠物信仰非盈利机构